Replies to post #78309 on Ocata Therapeutics Inc fka OCAT

[farviewhill]

Put it in your will Alteza, if it makes it that far.

Phases 2 and 3 are brutal and beyond incredibly expensive and have a FDA failure rate so incredibly high few realize.

The path of commercializing any possible science, from the standpoint of biotech investing, is probably one of the worse going. A point sadly missed by all those with rosey glasses.
Put it in your will if the company ever gets that far.

Remember the last 10 years and we still haven't completed phase 1 and have financing left for about three months and apparently sad prospects for sound proposed financial underwriting. What does it take?